Keywords: dainippon, sumitomo, income, leaps, osaka, japan-headquartered, drugmaker
Dainippon Sumitomo's income leaps 16%
Article | 22 May 2006
Osaka, Japan-headquartered drugmaker Dainippon Sumitomo says that its operating income for the financial year ended March 31, 2006, hit 44.7 billion yen ($406.3 million) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
